Abstract
MOLECULAR QUANTUM AND LOGIC PROCESS OF CONSCIOUSNESS—VITAMIN D BIG-DATA IN COVID-19—A CASE FOR INCORPORATING MACHINE LEARNING IN MEDICINE

Athula K. Polonowita and Sunil J. Wimalawansa*

ABSTRACT

There are unique relations between statistics and logic operating in neural networks in the human brain. Like machine learning, big data and artificial intelligence (AI) techniques could emulate human brain functions rapidly and assist healthcare decisions, especially in emergencies like COVID-19. We explore published positive modulatory effects of vitamin D on the human immune system from randomized control clinical trials (RCTs) and meta-analyses taken as an example. The analysis confirmed a robust negative correlation between serum 25(OH)D concentration with increased susceptibility to symptomatic SARS-CoV-2, complications, hospitalization, and deaths. Instead of using available such data in mid-2020, regulators relied upon RCTs from big pharma. Utilizing advanced Machine Learning paradigms using cleaned data would have expedited proper decision-making, better guidance on patient management, and approval of cost-effective early therapies like vitamin D and calcifediol, reducing the cost of care and millions of hospitalizations and deaths from SARS-CoV-2. Using Catuskoti logic in AI, broader than Boolean logic would have enhanced unbiased decision-making and developed data-driven algorithms to control outbreaks. Scientific evidence existed in mid-2020 that vitamin D and calcifediol rapidly boost the immune system, thus preventing SARS-CoV-2-related complications and deaths. However, statistical misconceptions, lack of broader vision, and failure to use big data analysis and machine learning approaches prevented using generic agents as prophylactic and adjunct therapies. We present the argument for hypothesis generation in conjunction with innovation in machine learning, using Catuskoti-based XOR and XNOR circuits as a solution to expedite the categorization of vulnerability, developing practical algorithms, and rapid approvals of repurposed drugs for future pandemics. Such data-driven analyses through machine learning programs minimize conflicts of interest and expedite decision-making. In the future, big data can be analyzed using desktop computers, facilitating prompt and proper decision-making and expedited drug approvals, especially for generics. This approach will better manage future epidemics and pandemics—cost-effective early therapeutic interventions, preventing complications, hospitalizations, and deaths, and reducing healthcare burden and cost.

Keywords: 25(OH)D; pandemic; randomized-controlled trial (RCT); SARS-CoV-2, Artificial intelligence.


[Full Text Article]   [Download Certificate]

Login





Forgot Password  |  Register

Indexing

Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation

  • EJBPS: APRIL ISSUE PUBLISHED

    APRIL 2024 Issue has been successfully launched on 1 APRIL 2024.

  • EJBPS New Impact Factor

    EJBPS Impact Factor has been Increased to 7.482 for Year 2024.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.

     

UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS

Downloads

Copyright From

Covering Letter

                        Author Instruction 
 

PLAGERLUM REPORT